Pubblicazioni

  1. Moroni, L, Veronica, B, Gallina, GD, Benanti, G, Cilona, M, Cariddi, A et al.. Step-down treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis: a real-life single-centre study. Rheumatology (Oxford). 2025; :. doi: 10.1093/rheumatology/keaf201. PubMed PMID:40221861 .
  2. Molteni, R, Fiumara, M, Campochiaro, C, Alfieri, R, Pacini, G, Licari, E et al.. Mechanisms of hematopoietic clonal dominance in VEXAS syndrome. Nat Med. 2025; :. doi: 10.1038/s41591-025-03623-9. PubMed PMID:40195449 .
  3. Giusti, B, Fibbi, G, Margheri, F, Serratì, S, Rossi, L, Poggi, F et al.. Editorial Expression of Concern: A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. Arthritis Res Ther. 2025;27 (1):73. doi: 10.1186/s13075-025-03549-0. PubMed PMID:40165240 PubMed Central PMC11956410.
  4. Bellando-Randone, S, Wilhalme, H, Bruni, C, Czirjak, L, Distler, O, Allanore, Y et al.. The effect of hydroxychloroquine on activities of daily living and hand function in systemic sclerosis: results from an analysis of the EUSTAR cohort. Arthritis Res Ther. 2025;27 (1):66. doi: 10.1186/s13075-025-03476-0. PubMed PMID:40148996 PubMed Central PMC11948955.
  5. Bandini, G, Campochiaro, C, Ciuti, G, Baccellieri, D, Ardita, V, Bellando Randone, S et al.. Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients. Eur J Intern Med. 2025; :. doi: 10.1016/j.ejim.2025.03.019. PubMed PMID:40140335 .
  6. Dubas, V, Buch, MH, Seferovic, P, Matucci-Cerinic, M, Bruni, C. International expert agreement on World Scleroderma Foundation/Heart Failure Association consensus-based definition and guidance on screening, diagnosis, and follow-up assessment of systemic sclerosis-associated primary heart involvement. J Scleroderma Relat Disord. 2025; :23971983251321691. doi: 10.1177/23971983251321691. PubMed PMID:40124985 PubMed Central PMC11924048.
  7. Boleto, G, Campochiaro, C, Distler, O, Balanescu, A, Launay, D, Bergmann, C et al.. Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis. J Scleroderma Relat Disord. 2025; :23971983251324827. doi: 10.1177/23971983251324827. PubMed PMID:40124983 PubMed Central PMC11924063.
  8. Cacco, T, Papa, R, Carmisciano, L, Bruzzo, C, Semino, L, Tonelli, A et al.. Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model. JBMR Plus. 2025;9 (4):ziaf029. doi: 10.1093/jbmrpl/ziaf029. PubMed PMID:40060915 PubMed Central PMC11890112.
  9. Abraham, DJ, Black, CM, Denton, CP, Distler, JHW, Domsic, R, Feghali-Bostwick, C et al.. Publisher Correction: An international perspective on the future of systemic sclerosis research. Nat Rev Rheumatol. 2025;21 (4):249. doi: 10.1038/s41584-025-01231-y. PubMed PMID:40032952 .
  10. Farina, N, De Luca, G, Peretto, G, Bartoli, A, Esposito, A, Matucci-Cerinic, M et al.. Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies. Rev Cardiovasc Med. 2025;26 (2):26605. doi: 10.31083/RCM26605. PubMed PMID:40026523 PubMed Central PMC11868888.
  11. Ferraioli, M, Levani, J, De Luca, R, Matucci-Cerinic, C, Gattorno, M, Guiducci, S et al.. What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review. J Clin Med. 2025;14 (4):. doi: 10.3390/jcm14041366. PubMed PMID:40004896 PubMed Central PMC11856149.
  12. Natoli, V, Palmeri, S, Rebollo-Giménez, AI, Matucci-Cerinic, C, Bocca, P, Caorsi, R et al.. Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib. Pediatr Rheumatol Online J. 2025;23 (1):22. doi: 10.1186/s12969-024-01044-5. PubMed PMID:40001174 PubMed Central PMC11863721.
  13. Abraham, DJ, Black, CM, Denton, CP, Distler, JHW, Domsic, R, Feghali-Bostwick, C et al.. An international perspective on the future of systemic sclerosis research. Nat Rev Rheumatol. 2025;21 (3):174-187. doi: 10.1038/s41584-024-01217-2. PubMed PMID:39953141 .
  14. Spierings, J, Bandini, G, Allanore, Y, Papa, ND, Denton, CP, Distler, O et al.. Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study. Semin Arthritis Rheum. 2025;71 :152638. doi: 10.1016/j.semarthrit.2025.152638. PubMed PMID:39914262 .
  15. Matucci-Cerinic, C, Attico, A, Malattia, C, Consolaro, A, Rosina, S, Breda, L et al.. Towards the definition of disease phenotypes in pediatric SAPHO syndrome: a national multicentric study. Rheumatology (Oxford). 2025; :. doi: 10.1093/rheumatology/keaf065. PubMed PMID:39909492 .
  16. Denton, CP, Kowal-Bielecka, O, Proudman, SM, Olesińska, M, Worm, M, Del Papa, N et al.. A Phase 2 randomised trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2025; :. doi: 10.1093/rheumatology/keaf066. PubMed PMID:39909490 .
  17. Bjørkekjær, HJ, Bruni, C, Broch, K, Brunborg, C, Carreira, PE, Airò, P et al.. A comparative analysis of risk stratification tools in systemic sclerosis-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology (Oxford). 2025; :. doi: 10.1093/rheumatology/keaf053. PubMed PMID:39878955 .
  18. Del Galdo, F, Lescoat, A, Conaghan, PG, Bertoldo, E, Čolić, J, Santiago, T et al.. EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Ann Rheum Dis. 2025;84 (1):29-40. doi: 10.1136/ard-2024-226430. PubMed PMID:39874231 .
  19. De Luca, G, De Santis, M, Batani, V, Tonutti, A, Campochiaro, C, Palmisano, A et al.. Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study. Semin Arthritis Rheum. 2025;71 :152622. doi: 10.1016/j.semarthrit.2024.152622. PubMed PMID:39826307 .
  20. Cacciapaglia, F, De Angelis, R, Ferri, C, Bajocchi, G, Bellando-Randone, S, Bruni, C et al.. Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. J Rheumatol. 2025;52 (4):375-382. doi: 10.3899/jrheum.2024-0750. PubMed PMID:39814435 .
  21. Bonomi, F, Bandini, G, Guiducci, S, Matucci-Cerinic, M, Bellando Randone, S. Unveiling the hidden trajectories of gastrointestinal disease in systemic sclerosis. Rheumatology (Oxford). 2024; :. doi: 10.1093/rheumatology/keae658. PubMed PMID:39724207 .
  22. Dobrota, R, Garaiman, A, Fligelstone, K, Tyrrell Kennedy, A, Roennow, A, Allanore, Y et al.. Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosis. RMD Open. 2024;10 (4):. doi: 10.1136/rmdopen-2024-004653. PubMed PMID:39608865 PubMed Central PMC11603699.
  23. Ramirez, GA, Calabrese, C, Secci, M, Moroni, L, Gallina, GD, Benanti, G et al.. Infection-Associated Flares in Systemic Lupus Erythematosus. Pathogens. 2024;13 (11):. doi: 10.3390/pathogens13110934. PubMed PMID:39599487 PubMed Central PMC11597141.
  24. Bellando-Randone, S, Russo, E, Di Gloria, L, Lepri, G, Baldi, S, Fioretto, BS et al.. Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile. RMD Open. 2024;10 (4):. doi: 10.1136/rmdopen-2024-004647. PubMed PMID:39557490 PubMed Central PMC11574430.
  25. Talarico, R, Marinello, D, Palla, I, Cannizzo, S, Galetti, I, Farrington, S et al.. Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients' care pathway. J Scleroderma Relat Disord. 2024; :23971983241269109. doi: 10.1177/23971983241269109. PubMed PMID:39544904 PubMed Central PMC11559522.
  26. Mongin, D, Matucci-Cerinic, M, Walker, UA, Distler, O, Becvar, R, Siegert, E et al.. Oral Glucocorticoids for Skin Fibrosis in Early Diffuse Systemic Sclerosis: A Target Trial Emulation Study From the European Scleroderma Trials and Research Group Database. Arthritis Care Res (Hoboken). 2024; :. doi: 10.1002/acr.25469. PubMed PMID:39542851 .
  27. Scaletti, C, Pratesi, S, Bellando Randone, S, Di Pietro, L, Campochiaro, C, Annunziato, F et al.. The B-cells paradigm in systemic sclerosis: an update on pathophysiology and B-cell-targeted therapies. Clin Exp Immunol. 2025;219 (1):. doi: 10.1093/cei/uxae098. PubMed PMID:39498828 PubMed Central PMC11754866.
  28. Avanoglu Guler, A, De Luca, G, Dagna, L, Matucci-Cerinic, M, Campochiaro, C. Unraveling the Pathogenesis of Calcinosis in Systemic Sclerosis: A Molecular and Clinical Insight. Int J Mol Sci. 2024;25 (20):. doi: 10.3390/ijms252011257. PubMed PMID:39457038 PubMed Central PMC11508720.
  29. Colic, J, Campochiaro, C, Matucci-Cerinic, M. Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!. Rheumatol Immunol Res. 2024;5 (3):136-140. doi: 10.2478/rir-2024-0019. PubMed PMID:39439979 PubMed Central PMC11492820.
  30. Bandini, G, Monami, M, Ciuti, G, Mercatelli, P, Lo Cricchio, A, De Santis, MC et al.. Doppler ultrasound, a noninvasive tool for the study of mesenteric arterial flow in systemic sclerosis: a cross-sectional study of a patient cohort with review and meta-analysis of the literature. Intern Emerg Med. 2025;20 (2):381-394. doi: 10.1007/s11739-024-03783-5. PubMed PMID:39412608 PubMed Central PMC11950030.
  31. Zhang, W, Huang, G, Zheng, S, Lin, J, Hu, S, Zhuang, J et al.. Risk prediction modelling in idiopathic inflammatory myositis-associated interstitial lung disease based on seven factors including serum KL-6 and lung ultrasound B-lines. Clin Exp Rheumatol. 2025;43 (2):260-268. doi: 10.55563/clinexprheumatol/ylf0oe. PubMed PMID:39360376 .
  32. De Lorenzis, E, Natalello, G, Pellegrino, G, Verardi, L, Batani, V, Lepri, G et al.. Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology (Oxford). 2025;64 (4):1966-1974. doi: 10.1093/rheumatology/keae532. PubMed PMID:39348184 .
  33. Wang, Y, Chen, S, Zheng, S, Zhou, Z, Zhang, W, Du, G et al.. A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review. Arthritis Res Ther. 2024;26 (1):164. doi: 10.1186/s13075-024-03399-2. PubMed PMID:39294670 PubMed Central PMC11409780.
  34. Chen, S, Fan, Y, Wu, Q, Zhang, G, Wang, Y, Li, W et al.. Integrative Transcriptomic Analysis of Peripheral Blood Monocytes in Systemic Sclerosis and Shared Pathogenic Pathways in Autoimmune Diseases. Arch Med Res. 2025;56 (1):103072. doi: 10.1016/j.arcmed.2024.103072. PubMed PMID:39208548 .
  35. Coccia, C, Bonomi, F, Lo Cricchio, A, Russo, E, Peretti, S, Bandini, G et al.. The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases. Biomedicines. 2024;12 (8):. doi: 10.3390/biomedicines12081760. PubMed PMID:39200224 PubMed Central PMC11351188.
  36. Bellini, T, Bustaffa, M, Tubino, B, Giordano, B, Formigoni, C, Fueri, E et al.. Acquired and Inherited Zinc Deficiency-Related Diseases in Children: A Case Series and a Narrative Review. Pediatr Rep. 2024;16 (3):602-617. doi: 10.3390/pediatric16030051. PubMed PMID:39189285 PubMed Central PMC11348185.
  37. Caorsi, R, Bertoni, A, Matucci-Cerinic, C, Natoli, V, Palmeri, S, Rosina, S et al.. Long-term efficacy of MAS825, a bispecific anti-IL1β and IL-18 monoclonal antibody, in two patients with systemic JIA and recurrent episodes of macrophage activation syndrome. Rheumatology (Oxford). 2025;64 (3):1528-1533. doi: 10.1093/rheumatology/keae440. PubMed PMID:39178016 PubMed Central PMC11879313.
  38. Orlandi, M, Bellando-Randone, S, De Angelis, R, Ferri, C, Giuggioli, D, Cacciapaglia, F et al.. Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry. Eur J Intern Med. 2024;130 :130-136. doi: 10.1016/j.ejim.2024.07.040. PubMed PMID:39147653 .
  39. Markousis-Mavrogenis, G, Sfikakis, PP, Kwong, AHS, Pepe, A, Matucci-Cerinic, M, Kitas, GD et al.. Cardiovascular Magnetic Resonance for the Evaluation of Arrhythmogenic Substrates in Patients with Systemic Autoimmunity: An Update. Rev Cardiovasc Med. 2023;24 (10):290. doi: 10.31083/j.rcm2410290. PubMed PMID:39077573 PubMed Central PMC11273118.
  40. Velauthapillai, A, Bootsma, MFR, Bruni, C, Bergmann, C, Matucci-Cerinic, M, Launay, D et al.. Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology (Oxford). 2024; :. doi: 10.1093/rheumatology/keae375. PubMed PMID:39037917 .
  41. Matucci-Cerinic, C, Herzum, A, Ciccarese, G, Rosina, S, Caorsi, R, Gattorno, M et al.. Therapeutic Role of HPV Vaccination on Benign HPV-induced Epithelial Proliferations in Immunocompetent and Immunocompromised Patients: Case Study and Review of the Literature. Open Forum Infect Dis. 2024;11 (7):ofae369. doi: 10.1093/ofid/ofae369. PubMed PMID:39035570 PubMed Central PMC11259138.
  42. El Aoufy, K, Melis, MR, Magi, CE, Bellando-Randone, S, Tamburini, M, Bandini, G et al.. Evidence for telemedicine heterogeneity in rheumatic and musculoskeletal diseases care: a scoping review. Clin Rheumatol. 2024;43 (9):2721-2763. doi: 10.1007/s10067-024-07052-w. PubMed PMID:38985235 PubMed Central PMC11330403.
  43. Farina, N, Tomelleri, A, Boffini, N, Cariddi, A, Calvisi, S, Viapiana, N et al.. Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort. Scand J Rheumatol. 2024;53 (6):428-432. doi: 10.1080/03009742.2024.2353433. PubMed PMID:38832522 .
  44. Ciaffi, J, Liem, SIE, Cannegieter, S, Ahmed, S, Hoekstra, EM, Wiland, P et al.. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD Open. 2024;10 (2):. doi: 10.1136/rmdopen-2024-004101. PubMed PMID:38772679 PubMed Central PMC11328649.
  45. Matucci-Cerinic, C, Corona, F, Varnier, GC, Pastore, S, Bocca, P, Palmeri, S et al.. Baricitinib treatment in children with COPA syndrome. J Allergy Clin Immunol Pract. 2024;12 (8):2201-2204. doi: 10.1016/j.jaip.2024.05.017. PubMed PMID:38768895 .
  46. De Luca, G, De Lorenzis, E, Campochiaro, C, Cacciapaglia, F, Del Papa, N, Zanatta, E et al.. Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study. Rheumatology (Oxford). 2025;64 (3):1284-1291. doi: 10.1093/rheumatology/keae280. PubMed PMID:38745439 PubMed Central PMC11879284.
  47. Mastrolia, MV, Matucci-Cerinic, C, Ozen, S, Kasapcopur, O, Gaggiano, C, Koné-Paut, I et al.. Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry. Semin Arthritis Rheum. 2024;66 :152454. doi: 10.1016/j.semarthrit.2024.152454. PubMed PMID:38678817 .
  48. Papa, R, Bertoni, A, Matucci-Cerinic, C, Drago, E, Liberatore, F, Corcione, A et al.. Interleukin 1 receptor antagonist as biomarker for disease flares in fibrodysplasia ossificans progressiva. Bone. 2024;184 :117110. doi: 10.1016/j.bone.2024.117110. PubMed PMID:38643896 .
  49. Dima, A, Vonk, MC, Garaiman, A, Kersten, BE, Becvar, R, Tomcik, M et al.. Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review. Eur J Intern Med. 2024;125 :104-110. doi: 10.1016/j.ejim.2024.03.035. PubMed PMID:38599922 .
  50. Matucci-Cerinic, M, Ciccia, F, Foti, R, Giunta, A, Loconsole, F, Prignano, F et al.. Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation. Rheumatol Immunol Res. 2024;5 (1):49-56. doi: 10.1515/rir-2024-0006. PubMed PMID:38571927 PubMed Central PMC10985702.
  51. Campochiaro, C, Farina, N, De Luca, G, Batani, V, Trignani, G, Vignale, D et al.. Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies. Arthritis Res Ther. 2024;26 (1):79. doi: 10.1186/s13075-024-03310-z. PubMed PMID:38570792 PubMed Central PMC10988925.
  52. Zhang, MD, Huang, WY, Luo, JY, He, RQ, Huang, ZG, Li, JD et al.. The 'whole landscape' of research on systemic sclerosis over the past 73 years. Autoimmun Rev. 2024;23 (5):103538. doi: 10.1016/j.autrev.2024.103538. PubMed PMID:38556034 .
  53. Avanoglu-Guler, A, Campochiaro, C, De Luca, G, Hughes, M, Tufan, A, Green, L et al.. Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients' hands. Semin Arthritis Rheum. 2024;66 :152431. doi: 10.1016/j.semarthrit.2024.152431. PubMed PMID:38537324 .
  54. El Aoufy, K, Melis, MR, Iovino, P, Bambi, S, Lorini, C, Bonaccorsi, G et al.. The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian Cohort. Nurs Rep. 2024;14 (1):556-565. doi: 10.3390/nursrep14010043. PubMed PMID:38535715 PubMed Central PMC10976134.
  55. Cometi, L, Francesconi, P, Bellini, B, Turco, L, Voller, F, Nacci, F et al.. Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience. Reumatismo. 2024;76 (1):. doi: 10.4081/reumatismo.2024.1547. PubMed PMID:38523585 .
  56. Damiani, A, Orlandi, M, Bruni, C, Bandini, G, Lepri, G, Scaletti, C et al.. The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review. Respir Res. 2024;25 (1):138. doi: 10.1186/s12931-024-02725-1. PubMed PMID:38521926 PubMed Central PMC10960984.
  57. Treppo, E, Isola, M, De Martino, M, Padoan, R, Giollo, A, Urban, ML et al.. Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire. Rheumatol Adv Pract. 2024;8 (1):rkae001. doi: 10.1093/rap/rkae001. PubMed PMID:38515585 PubMed Central PMC10956719.
  58. Lescoat, A, Khanna, D, Kuwana, M, Allanore, Y, Matucci-Cerinic, M. Pre-scleroderma and new opportunities for preventive medicine - Authors' reply. Lancet Rheumatol. 2024;6 (4):e201. doi: 10.1016/S2665-9913(24)00058-4. PubMed PMID:38508819 .
  59. Farina, N, Tomelleri, A, Boffini, N, Cariddi, A, Calvisi, S, Baldissera, E et al.. Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease. Rheumatol Int. 2024;44 (11):2431-2434. doi: 10.1007/s00296-024-05571-y. PubMed PMID:38506924 .
  60. Loganathan, A, Zanframundo, G, Yoshida, A, Faghihi-Kashani, S, Bauer Ventura, I, Dourado, E et al.. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank. Clin Exp Rheumatol. 2024;42 (2):277-287. doi: 10.55563/clinexprheumatol/s14zq8. PubMed PMID:38488094 .
  61. Khanna, D, Kramer, F, Höfler, J, Ghadessi, M, Sandner, P, Allanore, Y et al.. Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2024;63 (11):3124-3134. doi: 10.1093/rheumatology/keae150. PubMed PMID:38460548 PubMed Central PMC11534119.
  62. D'Angelo, S, Tirri, E, Giardino, AM, De Rosa, T, Matucci-Cerinic, M, Dagna, L et al.. Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study. Int J Rheum Dis. 2024;27 (3):e15091. doi: 10.1111/1756-185X.15091. PubMed PMID:38433479 .
  63. Bandini, G, Alunno, A, Oliveira Pinheiro, F, Campochiaro, C, Galetti, I, Matucci Cerinic, P et al.. A multi-national survey to identify clinicians' perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis. Semin Arthritis Rheum. 2024;67 :152419. doi: 10.1016/j.semarthrit.2024.152419. PubMed PMID:38430623 .
  64. Bandini, G, Alunno, A, Alcacer-Pitarch, B, Ruaro, B, Galetti, I, El-Aoufy, K et al.. Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis. Rheumatology (Oxford). 2025;64 (3):1277-1283. doi: 10.1093/rheumatology/keae130. PubMed PMID:38430476 .
  65. Romanazzo, S, Ceccatelli, S, Mansueto, G, Sera, F, Guiducci, S, Matucci Cerinic, M et al.. Well-Being Therapy in systemic sclerosis outpatients: a randomized controlled trial. Rheumatology (Oxford). 2025;64 (2):667-674. doi: 10.1093/rheumatology/keae114. PubMed PMID:38366929 .
  66. Mavrogeni, SI, Fotis, L, Matucci-Cerinic, M. Editorial: Cardiovascular involvement in autoimmune diseases, volume II. Front Cardiovasc Med. 2024;11 :1352268. doi: 10.3389/fcvm.2024.1352268. PubMed PMID:38357516 PubMed Central PMC10864634.
  67. Wong, GYM, Wadhawan, H, Roth Cardoso, V, Bravo Merodio, L, Rajeev, Y, Maldonado, RD et al.. 30-day Morbidity and Mortality after Cholecystectomy for Benign Gallbladder Disease (AMBROSE): A Prospective, International Collaborative Cohort Study. Ann Surg. 2024;281 (2):312-21. doi: 10.1097/SLA.0000000000006236. PubMed PMID:38348652 PubMed Central PMC11723498.
  68. Lepri, G, Bruni, C, Tofani, L, Moggi-Pignone, A, Orlandi, M, Tomassetti, S et al.. The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database. Diagnostics (Basel). 2024;14 (3):. doi: 10.3390/diagnostics14030295. PubMed PMID:38337811 PubMed Central PMC10855256.
  69. Riccieri, V, Pellegrino, G, Cipolletta, E, Giuggioli, D, Bajocchi, G, Bellando-Randone, S et al.. Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry. J Scleroderma Relat Disord. 2024;9 (1):38-49. doi: 10.1177/23971983231209809. PubMed PMID:38333531 PubMed Central PMC10848931.
  70. De Luca, G, Campochiaro, C, Burastero, SE, Matucci-Cerinic, M, Doglioni, C, Dagna, L et al.. Periostin expression in uninvolved skin as a potential biomarker for rapid cutaneous progression in systemic sclerosis patients: a preliminary explorative study. Front Med (Lausanne). 2023;10 :1214523. doi: 10.3389/fmed.2023.1214523. PubMed PMID:38327271 PubMed Central PMC10847316.
  71. Bruni, C, Tofani, L, Garaiman, A, Jordan, S, Mihai, CM, Dobrota, R et al.. Histogram-Based Densitometry Index to Assess the Severity of Interstitial Lung Disease in Systemic Sclerosis in Standard and Low-Dose Computed Tomography. J Rheumatol. 2024;51 (3):270-276. doi: 10.3899/jrheum.2023-0415. PubMed PMID:38302169 .
  72. Matucci-Cerinic, C, Viglizzo, G, Gattorno, M. SAPHO syndrome: Patient stratification and the new horizon of precision medicine. Semin Arthritis Rheum. 2024;65 :152373. doi: 10.1016/j.semarthrit.2024.152373. PubMed PMID:38290373 .
  73. Lepri, G, Hughes, M, Allanore, Y, Denton, CP, Furst, DE, Wang, Y et al.. The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution. Lancet Rheumatol. 2023;5 (7):e422-e425. doi: 10.1016/S2665-9913(23)00100-5. PubMed PMID:38251553 .
  74. Lescoat, A, Bellando-Randone, S, Campochiaro, C, Del Galdo, F, Denton, CP, Farrington, S et al.. Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. Lancet Rheumatol. 2023;5 (11):e683-e694. doi: 10.1016/S2665-9913(23)00212-6. PubMed PMID:38251534 .
  75. Distler, O, Allanore, Y, Denton, CP, Kuwana, M, Matucci-Cerinic, M, Pope, JE et al.. Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial. Lancet Rheumatol. 2023;5 (11):e660-e669. doi: 10.1016/S2665-9913(23)00238-2. PubMed PMID:38251533 .
  76. Palmeri, S, Penco, F, Bertoni, A, Bustaffa, M, Matucci-Cerinic, C, Papa, R et al.. Pyrin Inflammasome Activation Defines Colchicine-Responsive SURF Patients from FMF and Other Recurrent Fevers. J Clin Immunol. 2024;44 (2):49. doi: 10.1007/s10875-023-01649-7. PubMed PMID:38231350 .
  77. Gargani, L, Bruni, C, Todiere, G, Pugliese, NR, Bandini, G, Bellando-Randone, S et al.. Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis. J Clin Med. 2023;13 (1):. doi: 10.3390/jcm13010089. PubMed PMID:38202095 PubMed Central PMC10779804.
  78. Tani, C, Cardelli, C, Depascale, R, Gamba, A, Iaccarino, L, Doria, A et al.. Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study. J Transl Autoimmun. 2023;7 :100221. doi: 10.1016/j.jtauto.2023.100221. PubMed PMID:38162456 PubMed Central PMC10755036.
  79. Kaya Akca, U, Batu, ED, Jelusic, M, Calatroni, M, Bakry, R, Frkovic, M et al.. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children. Rheumatology (Oxford). 2024;63 (SI2):SI122-SI128. doi: 10.1093/rheumatology/kead693. PubMed PMID:38135503 .
  80. Galluccio, F, Cassisa, A, Matucci-Cerinic, M. Role of ultrasound in guiding the biopsy site in eosinophilic fasciitis. Rheumatol Immunol Res. 2023;4 (4):219-221. doi: 10.2478/rir-2023-0032. PubMed PMID:38125640 PubMed Central PMC10729588.
  81. Bandini, G, Alunno, A, Pinheiro, FO, Campochiaro, C, Galetti, I, Matucci-Cerinic, P et al.. A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2024;76 (5):608-615. doi: 10.1002/acr.25280. PubMed PMID:38111164 .
  82. Melchiorre, D, Passalacqua, M, Maresca, M, Landi, G, Bagni, MA, El Aoufy, K et al.. The effect of a combined rehabilitation program on the temporomandibular joint in systemic sclerosis evaluated by ultrasound exam. J Ultrasound. 2024;27 (2):297-302. doi: 10.1007/s40477-023-00839-8. PubMed PMID:38097897 PubMed Central PMC11178700.
  83. Migliore, A, Maheu, E, Saccone, L, de Campos, GC, Alekseeva, L, Chevalier, X et al.. What We Should Expect from an Innovative Intra-Articular Hyaluronic Acid Product: Expert Opinion Based on a Comprehensive Review of the Literature. J Clin Med. 2023;12 (23):. doi: 10.3390/jcm12237422. PubMed PMID:38068476 PubMed Central PMC10707195.
  84. Landini, N, Orlandi, M, Calistri, L, Nardi, C, Ciet, P, Bellando-Randone, S et al.. Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests. Eur J Radiol. 2024;170 :111239. doi: 10.1016/j.ejrad.2023.111239. PubMed PMID:38056347 .
  85. Nardi, C, Magnini, A, Calistri, L, Cavigli, E, Peired, AJ, Rastrelli, V et al.. Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes. BMC Pulm Med. 2023;23 (1):472. doi: 10.1186/s12890-023-02763-3. PubMed PMID:38007479 PubMed Central PMC10675953.
  86. Matucci-Cerinic, C, Palluy, H, Al-Mayouf, SM, Brogan, PA, Cantarini, L, Gul, A et al.. Validation of the PEDiatric Behçet's Disease classification criteria: an evidence-based approach. Rheumatology (Oxford). 2024;63 (12):3422-3431. doi: 10.1093/rheumatology/kead609. PubMed PMID:37991850 PubMed Central PMC11636558.
  87. Gargani, L, Pugliese, NR, De Biase, N, Mazzola, M, Agoston, G, Arcopinto, M et al.. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation. J Am Coll Cardiol. 2023;82 (21):1973-1985. doi: 10.1016/j.jacc.2023.09.807. PubMed PMID:37968015 .
  88. De Luca, G, Matucci-Cerinic, M, Mavrogeni, SI. Diagnosis and management of primary heart involvement in systemic sclerosis. Curr Opin Rheumatol. 2024;36 (1):76-93. doi: 10.1097/BOR.0000000000000990. PubMed PMID:37962165 .
  89. Petelytska, L, Bonomi, F, Cannistrà, C, Fiorentini, E, Peretti, S, Torracchi, S et al.. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review. RMD Open. 2023;9 (4):. doi: 10.1136/rmdopen-2023-003426. PubMed PMID:37940340 PubMed Central PMC10632935.
  90. Hughes, M, Allanore, Y, Baron, M, Del Galdo, F, Denton, CP, Frech, T et al.. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. Lancet Rheumatol. 2022;4 (11):e795-e803. doi: 10.1016/S2665-9913(22)00183-7. PubMed PMID:37936680 PubMed Central PMC10628971.
  91. Natalello, G, Bosello, SL, Campochiaro, C, Abignano, G, De Santis, M, Ferlito, A et al.. Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey. ACR Open Rheumatol. 2024;6 (1):14-20. doi: 10.1002/acr2.11627. PubMed PMID:37916477 PubMed Central PMC10789299.
  92. Marongiu, F, Ruberto, MF, Marongiu, S, Matucci Cerinic, M, Barcellona, D. A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis. Clin Exp Med. 2023;23 (8):4057-4064. doi: 10.1007/s10238-023-01222-x. PubMed PMID:37914967 .
  93. Ferri, C, Raimondo, V, Giuggioli, D, Gragnani, L, Lorini, S, Dagna, L et al.. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase. J Transl Autoimmun. 2023;7 :100212. doi: 10.1016/j.jtauto.2023.100212. PubMed PMID:37854035 PubMed Central PMC10580042.
  94. Matucci-Cerinic, C, Malattia, C, Pistorio, A, Rosina, S, Consolaro, A, Viola, S et al.. Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome. Semin Arthritis Rheum. 2023;63 :152277. doi: 10.1016/j.semarthrit.2023.152277. PubMed PMID:37839270 .
  95. Suliman, YA, Campochiaro, C, Hughes, M, Schoones, JW, Giuggioli, D, Moinzadeh, P et al.. Surgical management of digital ulcers in systemic sclerosis: A systematic literature review. Semin Arthritis Rheum. 2023;63 :152266. doi: 10.1016/j.semarthrit.2023.152266. PubMed PMID:37826898 .
  96. Guler, S, Sarbu, AC, Stalder, O, Allanore, Y, Bernardino, V, Distler, J et al.. Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis. Thorax. 2023;78 (12):1188-1196. doi: 10.1136/thorax-2023-220541. PubMed PMID:37798114 .
  97. De Luca, G, Campochiaro, C, Palmisano, A, Bruno, E, Vignale, D, Peretto, G et al.. Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities. Rheumatology (Oxford). 2024;63 (7):1902-1910. doi: 10.1093/rheumatology/kead541. PubMed PMID:37796832 PubMed Central PMC11215987.
  98. Campochiaro, C, Suliman, YA, Hughes, M, Schoones, JW, Giuggioli, D, Moinzadeh, P et al.. Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2023;63 :152267. doi: 10.1016/j.semarthrit.2023.152267. PubMed PMID:37778090 .
  99. Alten, R, Burmester, GR, Matucci-Cerinic, M, Salmon, JH, Östör, A, Ng, KJ et al.. Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients. Rheumatol Ther. 2023;10 (6):1575-1595. doi: 10.1007/s40744-023-00597-3. PubMed PMID:37755648 PubMed Central PMC10654280.
  100. Lepri, G, Airò, P, Distler, O, Andréasson, K, Braun-Moscovici, Y, Hachulla, E et al.. Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes. J Scleroderma Relat Disord. 2023;8 (3):210-220. doi: 10.1177/23971983231155948. PubMed PMID:37744053 PubMed Central PMC10515998.
  101. Bruni, C, Buch, MH, Djokovic, A, De Luca, G, Dumitru, RB, Giollo, A et al.. Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment. J Scleroderma Relat Disord. 2023;8 (3):169-182. doi: 10.1177/23971983231163413. PubMed PMID:37744047 PubMed Central PMC10515996.
  102. Campochiaro, C, Matucci-Cerinic, M. Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down. Rheumatology (Oxford). 2024;63 (3):589-590. doi: 10.1093/rheumatology/kead504. PubMed PMID:37738274 .
  103. Boleto, G, Reiseter, S, Hoffmann-Vold, AM, Mirouse, A, Cacoub, P, Matucci-Cerinic, M et al.. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease. Semin Arthritis Rheum. 2023;63 :152258. doi: 10.1016/j.semarthrit.2023.152258. PubMed PMID:37696231 .
  104. Campochiaro, C, Allanore, Y, Braun-Moscovici, Y, Matucci-Cerinic, M, Balbir-Gurman, A. Is cyclophosphamide still the gold standard in early severe rapidly progressive systemic sclerosis?. Autoimmun Rev. 2024;23 (1):103439. doi: 10.1016/j.autrev.2023.103439. PubMed PMID:37690478 .
  105. Rosa, I, Romano, E, Fioretto, BS, El Aoufy, K, Bellando-Randone, S, Matucci-Cerinic, M et al.. Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis. Cells. 2023;12 (17):. doi: 10.3390/cells12172195. PubMed PMID:37681927 PubMed Central PMC10486460.
  106. Müller-Ladner, U, Dignass, A, Gaffney, K, Jadon, D, Matucci-Cerinic, M, Lobaton, T et al.. The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease. BioDrugs. 2023;37 (6):873-889. doi: 10.1007/s40259-023-00616-3. PubMed PMID:37632666 PubMed Central PMC10581927.
  107. De Luca, G, Campochiaro, C, Peretto, G, Busnardo, E, Matucci-Cerinic, M, Dagna, L et al.. Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients. Clin Exp Rheumatol. 2023;41 (8):1723-1724. doi: 10.55563/clinexprheumatol/vxx4q7. PubMed PMID:37534954 .
  108. Colic, J, Campochiaro, C, Hughes, M, Matucci Cerinic, M, Dagna, L. Investigational drugs for the treatment of scleroderma: what's new?. Expert Opin Investig Drugs. 2023;32 (7):601-614. doi: 10.1080/13543784.2023.2242762. PubMed PMID:37526079 .
  109. Tomelleri, A, Benanti, G, Cariddi, A, Calvisi, SL, Baldissera, E, Boffini, N et al.. The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort. Rheumatology (Oxford). 2024;63 (2):e39-e42. doi: 10.1093/rheumatology/kead395. PubMed PMID:37522875 PubMed Central PMC10836993.
  110. Matteson, EL, Matucci-Cerinic, M, Kreuter, M, Burmester, GR, Dieudé, P, Emery, P et al.. Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open. 2023;9 (3):. doi: 10.1136/rmdopen-2023-003059. PubMed PMID:37507209 PubMed Central PMC10387655.
  111. Lepri, G, Orlandi, M, Bellando-Randone, S, Matucci-Cerinic, M, Guiducci, S. The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients. Clin Exp Rheumatol. 2023;41 (8):1575-1577. doi: 10.55563/clinexprheumatol/hgkk7b. PubMed PMID:37497726 .
  112. Colalillo, A, Pellicano, C, Ananyeva, LP, Hachulla, E, Cuomo, G, Györfi, AH et al.. Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care Res (Hoboken). 2025;77 (2):257-265. doi: 10.1002/acr.25196. PubMed PMID:37458105 PubMed Central PMC11771623.
  113. Lescoat, A, Huang, S, Carreira, PE, Siegert, E, de Vries-Bouwstra, J, Distler, JHW et al.. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatol. 2023;159 (8):837-847. doi: 10.1001/jamadermatol.2023.1729. PubMed PMID:37378994 PubMed Central PMC10308295.
  114. Farina, N, Campochiaro, C, Lescoat, A, Benanti, G, De Luca, G, Khanna, D et al.. Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis. Expert Rev Clin Immunol. 2023;19 (9):1131-1142. doi: 10.1080/1744666X.2023.2230370. PubMed PMID:37366065 .
  115. Ross, L, Maltez, N, Hughes, M, Schoones, JW, Baron, M, Chung, L et al.. Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review. Rheumatology (Oxford). 2023;62 (12):3785-3800. doi: 10.1093/rheumatology/kead289. PubMed PMID:37335850 PubMed Central PMC10691932.
  116. Russo, E, Bellando-Randone, S, Carboni, D, Fioretto, BS, Romano, E, Baldi, S et al.. The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis. Rheumatology (Oxford). 2024;63 (1):226-234. doi: 10.1093/rheumatology/kead208. PubMed PMID:37154625 .
  117. Spiera, R, Kuwana, M, Khanna, D, Hummers, L, Frech, TM, Stevens, W et al.. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2023;75 (9):1608-1618. doi: 10.1002/art.42510. PubMed PMID:37098795 .
  118. Frech, TM, Poole, JL, Murtaugh, M, Matucci-Cerinic, M. Expanding the Treatment Team: What Is the Role for Occupational Therapy, Physical Therapy, Wound Care, and Nutritional Support in Systemic Sclerosis?. Rheum Dis Clin North Am. 2023;49 (2):377-387. doi: 10.1016/j.rdc.2023.01.009. PubMed PMID:37028841 .
  119. Sutera, D, Bustaffa, M, Papa, R, Matucci-Cerinic, C, Matarese, S, D'Orsi, C et al.. Corrigendum to "Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF)" Seminars in Arthritis and Rheumatism 55 (2022) 152024. Semin Arthritis Rheum. 2023;60 :152195. doi: 10.1016/j.semarthrit.2023.152195. PubMed PMID:36990005 .
  120. Andreucci, E, Fioretto, BS, Rosa, I, Matucci-Cerinic, M, Biagioni, A, Romano, E et al.. Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts. Cells. 2023;12 (6):. doi: 10.3390/cells12060939. PubMed PMID:36980280 PubMed Central PMC10046917.
  121. Melis, MR, El Aoufy, K, Bambi, S, Bruni, C, Guiducci, S, Bellando-Randone, S et al.. Correction to: Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review. Clin Rheumatol. 2023;42 (6):1731. doi: 10.1007/s10067-023-06580-1. PubMed PMID:36933073 .
  122. De Angelis, R, Ferri, C, Giuggioli, D, Bajocchi, G, Dagna, L, Bellando-Randone, S et al.. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology. RMD Open. 2023;9 (1):. doi: 10.1136/rmdopen-2022-002890. PubMed PMID:36868782 PubMed Central PMC9990652.
  123. Zhang, W, Huang, G, Zheng, K, Lin, J, Hu, S, Zheng, S et al.. Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction. Clin Exp Rheumatol. 2023;41 (2):330-339. doi: 10.55563/clinexprheumatol/8ievtq. PubMed PMID:36861746 .
  124. Migliore, A, Alekseeva, L, Avasthi, SR, Bannuru, RR, Chevalier, X, Conrozier, T et al.. Early Osteoarthritis Questionnaire (EOAQ): a tool to assess knee osteoarthritis at initial stage. Ther Adv Musculoskelet Dis. 2023;15 :1759720X221131604. doi: 10.1177/1759720X221131604. PubMed PMID:36860967 PubMed Central PMC9969428.
  125. Fioretto, BS, Rosa, I, Matucci-Cerinic, M, Romano, E, Manetti, M. Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review. Int J Mol Sci. 2023;24 (4):. doi: 10.3390/ijms24044097. PubMed PMID:36835506 PubMed Central PMC9965592.
  126. Campochiaro, C, De Luca, G, Lazzaroni, MG, Armentaro, G, Spinella, A, Vigone, B et al.. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study. RMD Open. 2023;9 (1):. doi: 10.1136/rmdopen-2022-002850. PubMed PMID:36813476 PubMed Central PMC9950968.
  127. Cantoni, E, Merelli, I, Stefanoni, D, Tomelleri, A, Campochiaro, C, Giordano, V et al.. Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production. Rheumatology (Oxford). 2023;62 (10):3469-3479. doi: 10.1093/rheumatology/kead061. PubMed PMID:36802235 .
  128. Melis, MR, El Aoufy, K, Bambi, S, Bruni, C, Guiducci, S, Bellando-Randone, S et al.. Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review. Clin Rheumatol. 2023;42 (6):1521-1535. doi: 10.1007/s10067-023-06520-z. PubMed PMID:36801986 .
  129. Khanna, D, Denton, CP, Furst, DE, Mayes, MD, Matucci-Cerinic, M, Smith, V et al.. A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2023;75 (8):1434-1444. doi: 10.1002/art.42477. PubMed PMID:36787101 .
  130. Tomelleri, A, Campochiaro, C, Farina, N, Mariotti, L, Baldissera, E, Grayson, PC et al.. Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study. Semin Arthritis Rheum. 2023;59 :152174. doi: 10.1016/j.semarthrit.2023.152174. PubMed PMID:36774660 PubMed Central PMC9992325.
  131. El Aoufy, K, Pezzutto, A, Pollina, A, Rasero, L, Bambi, S, Bellando-Randone, S et al.. Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life. Int J Environ Res Public Health. 2023;20 (3):. doi: 10.3390/ijerph20032512. PubMed PMID:36767877 PubMed Central PMC9915443.
  132. Meloni, A, Gargani, L, Bruni, C, Cavallaro, C, Gobbo, M, D'Agostino, A et al.. Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma. Int J Cardiol. 2023;376 :139-146. doi: 10.1016/j.ijcard.2023.01.066. PubMed PMID:36731634 .
  133. Peretti, S, Torracchi, S, Russo, E, Bonomi, F, Fiorentini, E, Aoufy, KE et al.. The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review. Genes (Basel). 2022;14 (1):. doi: 10.3390/genes14010089. PubMed PMID:36672830 PubMed Central PMC9859330.
  134. Matucci-Cerinic, C, Engel, F, Lipsker, D. Early morphea appearing as a port-wine stain: A clinical challenge. Ann Dermatol Venereol. 2023;150 (2):148-151. doi: 10.1016/j.annder.2022.11.003. PubMed PMID:36658067 .
  135. Damiani, A, Bartoli, F, Pacini, G, Carboni, D, Bellando Randone, S, Fiori, G et al.. Persistence of remission after lengthening of golimumab in inflammatory joint diseases. Clin Exp Rheumatol. 2023;41 (5):1088-1095. doi: 10.55563/clinexprheumatol/k76z51. PubMed PMID:36622116 .
  136. Wang, Y, Xie, X, Zheng, S, Du, G, Chen, S, Zhang, W et al.. Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease. Front Med (Lausanne). 2022;9 :1066111. doi: 10.3389/fmed.2022.1066111. PubMed PMID:36590969 PubMed Central PMC9798453.
  137. Orlandi, M, Meliante, LA, Damiani, A, Tofani, L, Bruni, C, Guiducci, S et al.. The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review. Pharmaceuticals (Basel). 2022;15 (12):. doi: 10.3390/ph15121584. PubMed PMID:36559035 PubMed Central PMC9781787.
  138. Fiorentini, E, Bonomi, F, Peretti, S, Orlandi, M, Lepri, G, Matucci Cerinic, M et al.. Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data. Life (Basel). 2022;12 (12):. doi: 10.3390/life12122101. PubMed PMID:36556466 PubMed Central PMC9785277.
  139. Luciano, N, Fusaro, E, Ditto, MC, Ianniello, A, Bellis, E, Bruni, C et al.. Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study. Rheumatol Immunol Res. 2022;3 (1):31-37. doi: 10.2478/rir-2022-0005. PubMed PMID:36467021 PubMed Central PMC9524806.
  140. Mavrogeni, S, Pepe, A, Gargani, L, Bruni, C, Quaia, E, Kitas, GD et al.. Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update. Semin Arthritis Rheum. 2023;58 :152126. doi: 10.1016/j.semarthrit.2022.152126. PubMed PMID:36434895 .
  141. Agostini, E, De Luca, G, Bruni, C, Bartoli, F, Tofani, L, Campochiaro, C et al.. Corrigendum to "Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience" [Autoimmunity Reviews, Volume 20, Issue 12, December 2021, 102981]. Autoimmun Rev. 2023;22 (1):103198. doi: 10.1016/j.autrev.2022.103198. PubMed PMID:36402668 .
  142. Mormile, I, Mormile, M, Rossi, FW, Williams, M, Valente, T, Candia, C et al.. Radiological patterns and pulmonary function values of lung involvement in primary Sjögren's syndrome: A pilot analysis. Front Med (Lausanne). 2022;9 :998028. doi: 10.3389/fmed.2022.998028. PubMed PMID:36388884 PubMed Central PMC9649970.
  143. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment. Life (Basel). 2022;12 (11):. doi: 10.3390/life12111790. PubMed PMID:36362943 PubMed Central PMC9695837.
  144. Hughes, M, Umair, HM, Sandler, RD, Alunno, A, Matucci-Cerinic, M. Harnessing the therapeutic potential therapeutic efficacy of α-1 adrenergic blockers for Raynaud's phenomenon and digital ischaemia secondary to central nervous system stimulants used for attention deficit hyperactivity disorder. Semin Arthritis Rheum. 2022;57 :152114. doi: 10.1016/j.semarthrit.2022.152114. PubMed PMID:36356481 .
  145. Ruaro, B, Matucci Cerinic, M, Salton, F, Baratella, E, Confalonieri, M, Hughes, M et al.. Editorial: Pulmonary fibrosis: One manifestation, various diseases. Front Pharmacol. 2022;13 :1027332. doi: 10.3389/fphar.2022.1027332. PubMed PMID:36324683 PubMed Central PMC9620474.
  146. Elhai, M, Sritharan, N, Boubaya, M, Balbir-Gurman, A, Siegert, E, Hachulla, E et al.. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. Lancet Rheumatol. 2022;4 (11):e785-e794. doi: 10.1016/S2665-9913(22)00217-X. PubMed PMID:38265945 .
  147. Alten, R, Burmester, GR, Matucci-Cerinic, M, Salmon, JH, Lopez-Romero, P, Fakhouri, W et al.. The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis. Rheumatol Ther. 2023;10 (1):73-93. doi: 10.1007/s40744-022-00500-6. PubMed PMID:36227530 PubMed Central PMC9557042.
  148. Gremese, E, Ciccia, F, Selmi, C, Cuomo, G, Foti, R, Matucci-Cerinic, M et al.. Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort. Clin Exp Rheumatol. 2023;41 (3):735-743. doi: 10.55563/clinexprheumatol/j33pjt. PubMed PMID:36226614 .
  149. Bandeira, M, Di Cianni, F, Marinello, D, Arnaud, L, Cannizzo, S, Carta, C et al.. An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET. Front Med (Lausanne). 2022;9 :889997. doi: 10.3389/fmed.2022.889997. PubMed PMID:36226147 PubMed Central PMC9549150.
  150. Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Antunes, AM, Arnaud, L et al.. Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat Rev Rheumatol. 2022;18 (12):734. doi: 10.1038/s41584-022-00862-9. PubMed PMID:36203063 PubMed Central PMC9540116.
  151. Liem, SIE, Boonstra, M, le Cessie, S, Riccardi, A, Airo, P, Distler, O et al.. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts. Lancet Rheumatol. 2022;4 (10):e699-e709. doi: 10.1016/S2665-9913(22)00224-7. PubMed PMID:38265968 .
  152. Stamenkovic, B, Stojanovic, S, Zivkovic, V, Djordjevic, D, Bojanovic, M, Stankovic, A et al.. Low-Frequency Magnetic Resonance Imaging Identifies Hand Joint Subclinical Inflammation in Systemic Sclerosis. Diagnostics (Basel). 2022;12 (9):. doi: 10.3390/diagnostics12092165. PubMed PMID:36140568 PubMed Central PMC9497728.
  153. Lepri, G, Catalano, M, Bellando-Randone, S, Pillozzi, S, Giommoni, E, Giorgione, R et al.. Systemic Sclerosis Association with Malignancy. Clin Rev Allergy Immunol. 2022;63 (3):398-416. doi: 10.1007/s12016-022-08930-4. PubMed PMID:36121543 PubMed Central PMC9674744.
  154. Campochiaro, C, Farina, N, De Luca, G, Trignani, G, Tomelleri, A, Matucci-Cerinic, M et al.. Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review. J Rheumatol. 2023;50 (1):151-153. doi: 10.3899/jrheum.220213. PubMed PMID:36109081 .
  155. Bellando-Randone, S, Del Galdo, F, Matucci-Cerinic, M. Insights into molecular and clinical characteristics of very early systemic sclerosis. Curr Opin Rheumatol. 2022;34 (6):351-356. doi: 10.1097/BOR.0000000000000903. PubMed PMID:36082752 .
  156. Campochiaro, C, Lazzaroni, MG, Bruni, C, Zanatta, E, De Luca, G, Matucci-Cerinic, M et al.. Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review. Ther Adv Musculoskelet Dis. 2022;14 :1759720X221116408. doi: 10.1177/1759720X221116408. PubMed PMID:36051631 PubMed Central PMC9425887.
  157. Ruaro, B, Pozzan, R, Confalonieri, P, Tavano, S, Hughes, M, Matucci Cerinic, M et al.. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?. Pharmaceuticals (Basel). 2022;15 (8):. doi: 10.3390/ph15081033. PubMed PMID:36015181 PubMed Central PMC9412643.
  158. Taylor, PC, Matucci Cerinic, M, Alten, R, Avouac, J, Westhovens, R. Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes. Ther Adv Musculoskelet Dis. 2022;14 :1759720X221114101. doi: 10.1177/1759720X221114101. PubMed PMID:35991524 PubMed Central PMC9386864.
  159. Ferri, C, De Angelis, R, Giuggioli, D, Bajocchi, G, Dagna, L, Zanframundo, G et al.. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature. Autoimmun Rev. 2022;21 (10):103159. doi: 10.1016/j.autrev.2022.103159. PubMed PMID:35908642 .
  160. Garaiman, A, Steigmiller, K, Gebhard, C, Mihai, C, Dobrota, R, Bruni, C et al.. Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology (Oxford). 2023;62 (SI):SI91-SI100. doi: 10.1093/rheumatology/keac405. PubMed PMID:35904554 .
  161. Romano, E, Rosa, I, Fioretto, BS, Giuggioli, D, Manetti, M, Matucci-Cerinic, M et al.. Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells. Rheumatology (Oxford). 2023;62 (SI):SI125-SI137. doi: 10.1093/rheumatology/keac433. PubMed PMID:35900177 .
  162. Bonomi, F, Peretti, S, Lepri, G, Venerito, V, Russo, E, Bruni, C et al.. The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review. J Pers Med. 2022;12 (8):. doi: 10.3390/jpm12081198. PubMed PMID:35893293 PubMed Central PMC9331823.
  163. Hoffmann-Vold, AM, Distler, O, Bruni, C, Denton, CP, de Vries-Bouwstra, J, Matucci Cerinic, M et al.. Systemic sclerosis in the time of COVID-19. Lancet Rheumatol. 2022;4 (8):e566-e575. doi: 10.1016/S2665-9913(22)00130-8. PubMed PMID:35891634 PubMed Central PMC9302939.
  164. Romano, E, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Manetti, M. Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis. Life (Basel). 2022;12 (7):. doi: 10.3390/life12071056. PubMed PMID:35888144 PubMed Central PMC9316343.
  165. Bruni, C, Mattolini, L, Tofani, L, Gargani, L, Landini, N, Roma, N et al.. Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic Sclerosis. Diagnostics (Basel). 2022;12 (7):. doi: 10.3390/diagnostics12071696. PubMed PMID:35885600 PubMed Central PMC9316638.
  166. Santiago, T, Santos, EJF, Ruaro, B, Lepri, G, Green, L, Wildt, M et al.. Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group. RMD Open. 2022;8 (2):. doi: 10.1136/rmdopen-2022-002371. PubMed PMID:35850975 PubMed Central PMC9297224.
  167. Bandini, G, Accogli, E, Cometi, L, Matucci-Cerinic, M, Moggi Pignone, A. Ultrasound assessment of splanchnic circulation in Systemic Sclerosis: a non-invasive approach for the study of bowel vasculopathy?. Eur J Intern Med. 2022;103 :120-121. doi: 10.1016/j.ejim.2022.06.024. PubMed PMID:35821193 .
  168. Campochiaro, C, Farina, N, Tomelleri, A, Ferrara, R, Viola, S, Lazzari, C et al.. Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors. Eur J Intern Med. 2022;103 :95-99. doi: 10.1016/j.ejim.2022.07.005. PubMed PMID:35821192 .
  169. Zhang, W, Huang, G, Lin, J, Lin, Q, Zheng, K, Hu, S et al.. Predictive model of risk and severity of enteritis in systemic lupus erythematosus. Lupus. 2022;31 (10):1226-1236. doi: 10.1177/09612033221110743. PubMed PMID:35750508 .
  170. Hughes, M, Huang, S, Alegre-Sancho, JJ, Carreira, PE, Engelhart, M, Hachulla, E et al.. Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology (Oxford). 2023;62 (SI):SI54-SI63. doi: 10.1093/rheumatology/keac363. PubMed PMID:35731139 .
  171. Ferri, C, Raimondo, V, Gragnani, L, Giuggioli, D, Dagna, L, Tavoni, A et al.. Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies. Curr Pharm Des. 2022;28 (24):2022-2028. doi: 10.2174/1381612828666220614151732. PubMed PMID:35726427 .
  172. Bruni, C, Occhipinti, M, Pienn, M, Camiciottoli, G, Bartolucci, M, Bosello, SL et al.. Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023;62 (2):696-706. doi: 10.1093/rheumatology/keac311. PubMed PMID:35708639 .
  173. Kreuter, M, Hoffmann-Vold, AM, Matucci-Cerinic, M, Saketkoo, LA, Highland, KB, Wilson, H et al.. Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023;62 (SI):SI43-SI53. doi: 10.1093/rheumatology/keac325. PubMed PMID:35640959 PubMed Central PMC9910566.
  174. Sutera, D, Bustaffa, M, Papa, R, Matucci-Cerinic, C, Matarese, S, D'Orsi, C et al.. Clinical characterization, long-term follow-up, and response to treatment of patients with syndrome of undifferentiated recurrent fever (SURF). Semin Arthritis Rheum. 2022;55 :152024. doi: 10.1016/j.semarthrit.2022.152024. PubMed PMID:35598507 .
  175. Abouyahya, I, Liem, SIE, Amoura, Z, Fonseca, JE, Chaigne, B, Cutolo, M et al.. Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients. Clin Exp Rheumatol. 2022;40 Suppl 134 (5):66-70. doi: 10.55563/clinexprheumatol/x5aras. PubMed PMID:35579094 .
  176. Landini, N, Orlandi, M, Occhipinti, M, Nardi, C, Tofani, L, Bellando-Randone, S et al.. Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease. J Thorac Imaging. 2023;38 (2):97-103. doi: 10.1097/RTI.0000000000000637. PubMed PMID:35482025 .
  177. Farina, N, Benanti, G, De Luca, G, Palmisano, A, Peretto, G, Tomassetti, S et al.. The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis. J Multidiscip Healthc. 2022;15 :815-824. doi: 10.2147/JMDH.S295478. PubMed PMID:35480063 PubMed Central PMC9035450.
  178. Matucci-Cerinic, C, Viglizzo, G, Pastorino, C, Corcione, A, Prigione, I, Bocca, P et al.. Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome. Pediatr Allergy Immunol. 2022;33 (4):e13770. doi: 10.1111/pai.13770. PubMed PMID:35470938 PubMed Central PMC9321118.
  179. Bruni, C, Buch, MH, Furst, DE, De Luca, G, Djokovic, A, Dumitru, RB et al.. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition. J Scleroderma Relat Disord. 2022;7 (1):24-32. doi: 10.1177/23971983211053246. PubMed PMID:35386946 PubMed Central PMC8922675.
  180. El Aoufy, K, Bruni, C, Rasero, L, Matucci Cerinic, M, Furst, DE. Patient preferences for systemic sclerosis treatment: A descriptive study within an Italian cohort. J Scleroderma Relat Disord. 2021;6 (2):165-169. doi: 10.1177/2397198320971984. PubMed PMID:35386742 PubMed Central PMC8892923.
  181. Baldini, C, Arnaud, L, Avčin, T, Beretta, L, Bellocchi, C, Bouillot, C et al.. Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison. Clin Exp Rheumatol. 2022;40 Suppl 134 (5):103-112. doi: 10.55563/clinexprheumatol/3y0hqs. PubMed PMID:35349420 .
  182. Talarico, R, Aguilera, S, Alexander, T, Amoura, Z, Andersen, J, Arnaud, L et al.. The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET. Clin Exp Rheumatol. 2022;40 Suppl 134 (5):3-11. doi: 10.55563/clinexprheumatol/d2qz38. PubMed PMID:35349419 .
  183. Zanatta, E, Huscher, D, Ortolan, A, Avouac, J, Airò, P, Balbir-Gurman, A et al.. Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort. Rheumatology (Oxford). 2022;61 (12):4786-4796. doi: 10.1093/rheumatology/keac188. PubMed PMID:35348643 .
  184. Ruaro, B, Salton, F, Baratella, E, Confalonieri, P, Geri, P, Pozzan, R et al.. An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics (Basel). 2022;12 (3):. doi: 10.3390/diagnostics12030616. PubMed PMID:35328169 PubMed Central PMC8947575.
  185. Manetti, M, Rosa, I, Fioretto, BS, Matucci-Cerinic, M, Romano, E. Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis. J Clin Med. 2022;11 (5):. doi: 10.3390/jcm11051362. PubMed PMID:35268452 PubMed Central PMC8910971.
  186. Cavagna, L, Meloni, F, Meyer, A, Sambataro, G, Belliato, M, De Langhe, E et al.. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. Clin Exp Rheumatol. 2022;40 (2):274-283. doi: 10.55563/clinexprheumatol/di1083. PubMed PMID:35200123 .
  187. De Luca, G, Palmisano, A, Campochiaro, C, Vignale, D, Cavalli, G, Bruno, E et al.. Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation. Rheumatology (Oxford). 2022;61 (11):4409-4419. doi: 10.1093/rheumatology/keac098. PubMed PMID:35188182 .
  188. Landini, N, Orlandi, M, Bruni, C, Carlesi, E, Nardi, C, Calistri, L et al.. Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis-Interstitial Lung Disease: A Systematic Review. Front Med (Lausanne). 2021;8 :807982. doi: 10.3389/fmed.2021.807982. PubMed PMID:35155484 PubMed Central PMC8829727.
  189. Bruni, C, Gentileschi, S, Pacini, G, Bardelli, M, Tofani, L, Bartoli, F et al.. Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211033679. doi: 10.1177/1759720X211033679. PubMed PMID:35116080 PubMed Central PMC8804457.
  190. Bruni, C, Cigolini, C, Tesei, G, Cometi, L, Bartoli, F, Fiori, G et al.. Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases. Eur J Rheumatol. 2021;8 (4):190-195. doi: 10.5152/eurjrheum.2020.21162. PubMed PMID:35110179 PubMed Central PMC10176229.
  191. De Luca, G, Matucci-Cerinic, M, Dagna, L. Improvements of vascular outcomes in systemic sclerosis: halfway through, but still far to go. Rheumatology (Oxford). 2022;61 (7):2714-2716. doi: 10.1093/rheumatology/keac056. PubMed PMID:35094069 .
  192. Santaniello, M, Matucci-Cerinic, C, Natoli, V, Trincianti, C, Ridella, F, Ravelli, A et al.. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?. Pediatr Allergy Immunol. 2022;33 Suppl 27 (Suppl 27):102-104. doi: 10.1111/pai.13645. PubMed PMID:35080303 PubMed Central PMC9306717.
  193. Longo, D, Branchi, E, Matucci-Cerinic, P, Bagni, MA, Matucci-Cerinic, M, Melchiorre, D et al.. Shoulder impingement syndrome in water polo players: muscle shortening manoeuvre controls pain intensity, recovers function and normalizes sonographic parameters. J Ultrasound. 2022;25 (3):667-673. doi: 10.1007/s40477-021-00645-0. PubMed PMID:35060097 PubMed Central PMC9402839.
  194. Bandini, G, Cometi, L, Accogli, E, Domanico, A, Tofani, L, Bruni, C et al.. Ultrasound evaluation of bowel vasculopathy in systemic sclerosis. Eur J Intern Med. 2022;100 :62-68. doi: 10.1016/j.ejim.2022.01.026. PubMed PMID:35058148 .
  195. Paoloni, M, Agostini, F, Bernasconi, S, Bona, G, Cisari, C, Fioranelli, M et al.. Information Survey on the Use of Complementary and Alternative Medicine. Medicina (Kaunas). 2022;58 (1):. doi: 10.3390/medicina58010125. PubMed PMID:35056433 PubMed Central PMC8781067.
  196. Lepri, G, Bellando Randone, S, Matucci Cerinic, M, Guiducci, S. Early diagnosis of systemic sclerosis, where do we stand today?. Expert Rev Clin Immunol. 2022;18 (1):1-3. doi: 10.1080/1744666X.2022.2015327. PubMed PMID:35023438 .
  197. Chung, L, Spino, C, McLain, R, Johnson, SR, Denton, CP, Molitor, JA et al.. Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. Lancet Rheumatol. 2020;2 (12):e743-e753. doi: 10.1016/S2665-9913(20)30237-X. PubMed PMID:34966900 PubMed Central PMC8713509.
  198. Tomassetti, S, Colby, TV, Wells, AU, Poletti, V, Costabel, U, Matucci-Cerinic, M et al.. Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?. Ther Adv Musculoskelet Dis. 2021;13 :1759720X211059605. doi: 10.1177/1759720X211059605. PubMed PMID:34900002 PubMed Central PMC8664307.
  199. Migliore, A, Gigliucci, G, Alekseeva, L, Bannuru, RR, Blicharski, T, Diracoglu, D et al.. Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis. Orthop Res Rev. 2021;13 :255-273. doi: 10.2147/ORR.S336185. PubMed PMID:34880685 PubMed Central PMC8648269.
  200. Bellando-Randone, S, Del Galdo, F, Lepri, G, Minier, T, Huscher, D, Furst, DE et al.. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Lancet Rheumatol. 2021;3 (12):e834-e843. doi: 10.1016/S2665-9913(21)00244-7. PubMed PMID:38287630 .
Search PubMed